AbbVie: Kidney Failure, Chronic trials

The registry lists 12 Kidney Failure, Chronic studies with AbbVie as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 3 3Phase 4 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney DiseaseCompletedNCT02207088Phase 3Results posted
• A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisCompletedNCT01382212Phase 3Results posted
• Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid GlandsCompletedNCT01273597Results posted
• Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical PracticeTerminatedNCT01134315Results posted
• Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek ExperienceCompletedNCT01083186Results posted
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) PatientsCompletedNCT00224055Phase 4Results posted
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic AgentsCompletedNCT00224042Phase 4Results posted
• Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)WithdrawnNCT02806362Phase 3
• A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary HyperparathyroidismCompletedNCT01149291
• Comparison Between Effects of Two Iron Preparations on Protein in the UrineCompletedNCT00534144Phase 1
• Effect of Two Iron Preparations on Protein in the UrineCompletedNCT00354692Phase 4
• DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)CompletedNCT00224081Phase 4